201 related articles for article (PubMed ID: 23517599)
1. Reduction-sensitive degradable micellar nanoparticles as smart and intuitive delivery systems for cancer chemotherapy.
Sun H; Meng F; Cheng R; Deng C; Zhong Z
Expert Opin Drug Deliv; 2013 Aug; 10(8):1109-22. PubMed ID: 23517599
[TBL] [Abstract][Full Text] [Related]
2. Reduction-responsive polymeric micelles and vesicles for triggered intracellular drug release.
Sun H; Meng F; Cheng R; Deng C; Zhong Z
Antioxid Redox Signal; 2014 Aug; 21(5):755-67. PubMed ID: 24279980
[TBL] [Abstract][Full Text] [Related]
3. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
[TBL] [Abstract][Full Text] [Related]
4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
5. Current trends in the use of vitamin E-based micellar nanocarriers for anticancer drug delivery.
Muddineti OS; Ghosh B; Biswas S
Expert Opin Drug Deliv; 2017 Jun; 14(6):715-726. PubMed ID: 27560621
[TBL] [Abstract][Full Text] [Related]
6. Actively targeted delivery of anticancer drug to tumor cells by redox-responsive star-shaped micelles.
Shi C; Guo X; Qu Q; Tang Z; Wang Y; Zhou S
Biomaterials; 2014 Oct; 35(30):8711-22. PubMed ID: 25002267
[TBL] [Abstract][Full Text] [Related]
7. Smart pH-sensitive micelles based on redox degradable polymers as DOX/GNPs carriers for controlled drug release and CT imaging.
Xiong D; Zhang X; Peng S; Gu H; Zhang L
Colloids Surf B Biointerfaces; 2018 Mar; 163():29-40. PubMed ID: 29278801
[TBL] [Abstract][Full Text] [Related]
8. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
[TBL] [Abstract][Full Text] [Related]
9. Novel reduction-sensitive micellar nanoparticles assembled from Rituximab-doxorubicin conjugates as smart and intuitive drug delivery systems for the treatment of non-Hodgkin's lymphoma.
Yin H; Meng T; Shu L; Mao M; Zhou L; Chen H; Song D
Chem Biol Drug Des; 2017 Nov; 90(5):892-899. PubMed ID: 28440948
[TBL] [Abstract][Full Text] [Related]
10. Micelles As Delivery System for Cancer Treatment.
Keskin D; Tezcaner A
Curr Pharm Des; 2017; 23(35):5230-5241. PubMed ID: 28552065
[TBL] [Abstract][Full Text] [Related]
11. Folate-containing reduction-sensitive lipid-polymer hybrid nanoparticles for targeted delivery of doxorubicin.
Wu B; Yu P; Cui C; Wu M; Zhang Y; Liu L; Wang CX; Zhuo RX; Huang SW
Biomater Sci; 2015 Apr; 3(4):655-64. PubMed ID: 26222425
[TBL] [Abstract][Full Text] [Related]
12. Redox-sensitive self-assembled nanoparticles based on alpha-tocopherol succinate-modified heparin for intracellular delivery of paclitaxel.
Yang X; Cai X; Yu A; Xi Y; Zhai G
J Colloid Interface Sci; 2017 Jun; 496():311-326. PubMed ID: 28237749
[TBL] [Abstract][Full Text] [Related]
13. Calcium carbonate nanoparticles as cancer drug delivery system.
Maleki Dizaj S; Barzegar-Jalali M; Zarrintan MH; Adibkia K; Lotfipour F
Expert Opin Drug Deliv; 2015; 12(10):1649-60. PubMed ID: 26005036
[TBL] [Abstract][Full Text] [Related]
14. Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release.
Chen W; Zhong P; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
J Control Release; 2013 Aug; 169(3):171-9. PubMed ID: 23306022
[TBL] [Abstract][Full Text] [Related]
15. Redox Sensitive Polysaccharide Based Nanoparticles for Improved Cancer Treatment: A Comprehensive Review.
Ghassami E; Varshosaz J; Taymouri S
Curr Pharm Des; 2018; 24(28):3303-3319. PubMed ID: 30101696
[TBL] [Abstract][Full Text] [Related]
16. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
[TBL] [Abstract][Full Text] [Related]
17. Redox-Sensitive Micelles Based on O,N-Hydroxyethyl Chitosan-Octylamine Conjugates for Triggered Intracellular Delivery of Paclitaxel.
Huo M; Liu Y; Wang L; Yin T; Qin C; Xiao Y; Yin L; Liu J; Zhou J
Mol Pharm; 2016 Jun; 13(6):1750-62. PubMed ID: 27100204
[TBL] [Abstract][Full Text] [Related]
18. Novel Nanoprinting for Oral Delivery of Poorly Soluble Drugs.
Yilmaz C; Sarisozen C; Torchilin V; Busnaina A
Methodist Debakey Cardiovasc J; 2016 Sep; 12(3):157-162. PubMed ID: 27826370
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable Stimuli-Responsive Polymeric Micelles for Treatment of Malignancy.
Yan L; Li X
Curr Pharm Biotechnol; 2016; 17(3):227-36. PubMed ID: 26873075
[TBL] [Abstract][Full Text] [Related]
20. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
